Olivier Le Moal
- IceCure Medical (NASDAQ:ICCM) said it received a Notice of Allowance from the Japan Patent Office (JPO) for its novel cryogenic pump for cryoablation systems.
- The patent titled 'Cryogen Pump' will be in effect until 2041.
- A patent for this invention has already been issued in the EU and is pending in other major markets, including the U.S., the company added.
- The cryogenic pump is submersible in liquid nitrogen, improves the cooling rate during a procedure, and can be used for multiple procedures or longer duration procedures without the need to refill liquid nitrogen, according to the company.
- "This additional IP in Japan supports our distribution agreement with Terumo for our cryoablation systems in Japan," said IceCure's CEO Eyal Shamir.